| 98983-0 |
Methocarbamol |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Methocarbamol [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
98983-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Methocarbamol Ur Cfm-mCnc |
|
|
|
N |
|
Carbacot; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Robaxin; Skelex; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 98984-8 |
OXcarbazepine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
OXcarbazepine [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
98984-8 |
|
Confirm |
|
|
Both |
|
|
|
0 |
OXcarbazepine Ur Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; OXC; Point in time; QNT; Quan; Quant; Quantitative; Random; Trileptal; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 98985-5 |
10-Hydroxycarbazepine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
10-Hydroxycarbazepine [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
98985-5 |
|
Confirm |
|
|
Both |
|
|
|
0 |
10OH-Carbazepine Ur Cfm-mCnc |
|
|
|
N |
|
10,11-dihydro-10-hydroxycarbamazepine; 10-Hydroxy carbazepine; 10-hydroxycarbamazepine; 10-Monohydroxyoxcarbazepine; 10-OH-carbazepine; 10OH-Carbazepine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Licarbazepine; Mass concentration; Oxcarbazepine metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 98986-3 |
Chloride/Creatinine |
SRto |
Urine |
24H |
Qn |
|
|
ACTIVE |
Chloride/Creatinine [Molar ratio] in 24 hour Urine |
|
ADD |
DefinitionDescription |
|
|
mmol/mmol |
|
|
|
|
|
|
CHEM |
|
98986-3 |
|
|
|
|
Both |
|
|
|
0 |
Chloride/Creat 24h Ur-sRto |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Cl; Cl-; CR; Crea; Creat; QNT; Quan; Quant; Quantitative; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/mmol |
|
|
|
0 |
| 98987-1 |
C reactive protein |
ACnc |
Body fld |
Pt |
Qn |
|
|
ACTIVE |
C reactive protein [Units/volume] in Body fluid |
|
ADD |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
98987-1 |
|
|
|
|
Both |
|
|
|
0 |
CRP Fld-aCnc |
|
|
|
N |
|
Arbitrary concentration; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; CRP; Fl; Fld; FLU; Fluid; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Reac; React |
2.72 |
2.72 |
|
|
|
|
|
|
|
[arb'U]/L |
|
|
|
0 |
| 98988-9 |
Prolactin^45M post dose TRH IV |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Prolactin [Moles/volume] in Serum or Plasma --45 minutes post dose TRH IV |
|
ADD |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
98988-9 |
|
|
|
|
Observation |
|
|
|
0 |
Prolactin 45M p TRH IV SerPl-sCnc |
|
|
|
N |
|
45M p TRH IV; After; CHEMISTRY.CHALLENGE TESTING; Lactotropic hormone; Lactotropin; Level; Mammatropic hormone; Mammotropin; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PRL; Prol; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.72 |
2.72 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 98989-7 |
Neutrophils.band form/Leukocytes |
NFr.DF |
Bld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Band form neutrophils/Leukocytes [Pure number fraction] in Blood by Automated count |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
98989-7 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Neuts Band NFr.DF Bld Auto |
|
|
|
N |
|
Auto; Automated detection; Bands; Blood; bnd; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; N-Band; Neut; Neutr; Neutrophil; Neuts Band; Number fraction; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; WBC; WBCs; White blood cell; White blood cells; Whole blood |
2.72 |
2.72 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9899-6 |
P wave amplitude.lead V5 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
P wave amplitude in in lead V5 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9899-6 |
|
EKG |
|
|
Observation |
|
|
|
0 |
P wave Amp L-V5 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P' wave Amp L-V5; P wave Amp L-V5; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 98990-5 |
Methotrexate^18H post dose |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Methotrexate [Moles/volume] in Serum or Plasma --18 hour post dose |
|
ADD |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
98990-5 |
|
|
|
|
Observation |
|
|
|
0 |
MTX 18h p SerPl-sCnc |
|
|
|
N |
|
After; Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.72 |
2.72 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 98991-3 |
Methotrexate^5M post dose |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Methotrexate [Moles/volume] in Serum or Plasma --5 minutes post dose |
|
ADD |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
98991-3 |
|
|
|
|
Observation |
|
|
|
0 |
MTX 5M p dose SerPl-sCnc |
|
|
|
N |
|
5M p dose; After; Amethoperin; Amethopterin; DRUG/TOXICOLOGY; Drugs; Level; Methotrexat; MTX; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.72 |
2.72 |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 98992-1 |
Alpha-1-Acid glycoprotein/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Alpha-1-acid glycoprotein/Protein.total in Serum or Plasma by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
98992-1 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
A1acid Glycoprotein MFr SerPl Elph |
|
|
|
N |
|
A1; A1acid Glycoprotein; AAG; Acd; Acids; AGP; Alfa; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; gG; Glycoprot; Glycoproteins; GP; i; Mass fraction; Orosomucoid; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.72 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 98993-9 |
Alpha 1 antitrypsin/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Alpha 1 antitrypsin/Protein.total in Serum or Plasma by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
98993-9 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
A1AT MFr SerPl Elph |
|
|
|
N |
|
A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.72 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 98994-7 |
Alpha 1 antitrypsin |
MCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
98994-7 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
A1AT SerPl Elph-mCnc |
|
|
|
N |
|
A1; A1A; A1AT; A-1-AT; A1-AT; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; i; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 98995-4 |
Transferrin/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Transferrin/Protein.total in Serum or Plasma by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
CHEM |
|
98995-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Transferrin MFr SerPl Elph |
|
|
|
N |
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SPEP; SR; Tf; Tot; Totl; TP; Trf; TRFRN |
2.72 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 98996-2 |
Transferrin |
MCnc |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Transferrin [Mass/volume] in Serum or Plasma by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
98996-2 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Transferrin SerPl Elph-mCnc |
|
|
|
N |
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Siderophilin; SR; Tf; Trf; TRFRN |
2.72 |
2.72 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 98997-0 |
Haptoglobin/Protein.total |
MFr |
Ser/Plas |
Pt |
Qn |
Electrophoresis |
|
ACTIVE |
Haptoglobin/Protein.total in Serum or Plasma by Electrophoresis |
|
ADD |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
98997-0 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Haptoglob MFr SerPl Elph |
|
|
|
N |
|
Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Haptoglob; HEMATOLOGY/CELL COUNTS; HP; Hpt; Mass fraction; Percent; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SPEP; SR; Tot; Totl; TP |
2.72 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 98998-8 |
Erythrocyte/Specimen Volume |
VFr.DF |
BldCo |
Pt |
Qn |
Automated count |
|
ACTIVE |
Hematocrit [Pure volume fraction] of Cord blood by Automated count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
98998-8 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Hct VFr.DF BldCo Auto |
|
|
|
N |
|
Auto; Automated detection; Blood - (umbilical) cord; Cord (umbilical) blood; Cord bld; Cord blood; Discocyte; Elec; Elect; Electr; Erc; Erythrocytes; HEMATOLOGY/CELL COUNTS; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; Spec; Vol |
2.79 |
2.72 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT:Hematocrit as a component is not an adequate description for a ratio, therefore Hematocrit is kept as a synonym, and the actual component is expressed as it should be:Erythrocyte/Specimen Volume; |
0 |
| 98999-6 |
Nucleated cells |
NCnc |
Synv fld |
Pt |
Qn |
Automated count |
|
ACTIVE |
Nucleated cells [#/volume] in Synovial fluid by Automated count |
|
ADD |
DefinitionDescription |
|
|
x10^9/L |
|
|
|
|
|
|
HEM/BC |
|
98999-6 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Nuc cell # Snv Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cell; Cellularity; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; HEMATOLOGY/CELL COUNTS; Joint aspirate; Joint fld; Joint flu; Joint fluid; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid |
2.72 |
2.72 |
|
|
|
|
|
|
|
10*9/L |
|
|
|
0 |
| 99-2 |
Cefoperazone |
Susc |
Isolate |
Pt |
Qn |
MLC |
|
ACTIVE |
Cefoperazone [Susceptibility] by Minimum lethal concentration (MLC) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
99-2 |
|
MLC |
|
|
Observation |
|
|
|
0 |
Cefoperazone Islt MLC |
|
|
|
Y |
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefobid; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MBC; Minimum bactericidal concentration; Minimum lethal concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 990-2 |
D little i super little b Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
Di sup(b) Ag [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
990-2 |
|
|
|
|
Both |
|
|
|
0 |
Di sup(b) Ag RBC Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; D (little i) (little b); Dextro; Di sup(b); Di^b; Diego; Diego Blood Group System; Erythrocytes; Hematology; Heme; i; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 9900-2 |
P wave amplitude.lead V6 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
P wave amplitude in lead V6 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
9900-2 |
|
EKG |
|
|
Observation |
|
|
|
0 |
P wave Amp L-V6 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; P prime; P' wave Amp L-V6; P wave Amp L-V6; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 99000-2 |
Dysautonomia autoimmune Ab panel |
- |
Ser |
Pt |
- |
|
|
ACTIVE |
Dysautonomia autoimmune Ab panel - Serum |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SERO |
|
99000-2 |
|
|
|
|
Order |
|
|
|
0 |
Dysauto autoimmune Ab pnl Ser |
|
|
|
N |
|
Dysauto autoimmune Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pnl; Point in time; Random; Serology; Serum; SR |
2.72 |
2.72 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 99001-0 |
Leptospira weilii serovar Celledoni Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira weilii sv Celledoni Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
99001-0 |
|
Aggl |
|
|
Observation |
|
|
|
0 |
L weilii Celledoni Ab Titr Ser Aggl |
|
|
|
N |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L weilii Celledoni; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.72 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 99002-8 |
Leptospira santarosai serovar Alexi Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira santarosai sv Alexi Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
99002-8 |
|
Aggl |
|
|
Observation |
|
|
|
0 |
L santarosai Alexi Ab Titr Ser Aggl |
|
|
|
N |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); L santarosai Alexi; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.72 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 99003-6 |
Leptospira santarosai serovar Georgia Ab |
Titr |
Ser |
Pt |
SemiQn |
Aggl |
|
ACTIVE |
Leptospira santarosai sv Georgia Ab [Titer] in Serum by Agglutination |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
99003-6 |
|
Aggl |
|
|
Observation |
|
|
|
0 |
L santarosai Georgia Ab Titr Ser Aggl |
|
|
|
N |
|
ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); L santarosai Georgia; Leptospirosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.72 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |